Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 5/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.32 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | PGK1 | P00558 | 1/20 | 0.31 |
| ▸ | PGK2 | P07205 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL22390096 | 0.97 | FDPS (0.40) | FDPSLMNAPDE3AADRB3PDE4D | |
| SCHEMBL6522336 | 0.84 | OR51E2 (0.52) | FDPSPGK1PGK2 | |
| Serine SCHEMBL8164452 | 0.82 | SLC1A1 (0.37) | — | |
| SCHEMBL5904251 | 0.81 | FDPS (0.32) | FDPS | |
| SCHEMBL4867881 | 0.81 | PGD (0.33) | FDPSTSHR | |
| Spermidine SCHEMBL15019657 | 0.77 | CA12 (0.44) | FDPSLMNAPDE3ATSHRMEN1 | |
| SCHEMBL8017415 | 0.77 | FDPS (0.41) | FDPSLMNATSHRALDH1A1 | |
| SCHEMBL19043011 | 0.77 | FDPS (0.43) | FDPSLMNAPDE3AADRB3PDE4D | |
| SCHEMBL7107604 | 0.77 | ALDH1A1 (0.46) | FDPSLMNAPDE3AADRB3PDE4D | |
| SCHEMBL10423090 | 0.75 | CA4 (0.36) | FDPSLMNAPDE3AADRB3PDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2482 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035705-A1 | ENGINEERED MICROORGANISMS WITH G3P ->3PG ENZYME AND/OR FRUCTOSE-1,6-BISPHOSPHATASE INCLUDING THOSE HAVING SYNTHETIC OR ENHANCED METHYLOTROPHY | AGAIN BIO APS (DK) | 2026-02-05 | — | — | US | claimed |
| US-20250333686-A1 | RECOMBINANT HOST CELLS AND METHODS FOR THE PRODUCTION OF GLYCERIC ACID AND DOWNSTREAM PRODUCTS | LYGOS, INC. (US) | 2025-10-30 | — | — | US | claimed |
| EP-4620484-A1 | METHOD FOR MODULATING KINASE ACTIVITY AND USE THEREOF | Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences (CN) | 2025-09-24 | — | — | EP | claimed |
| US-20250244328-A1 | APPARATUS AND METHODS USING TETHERED ENZYMES FOR THE DETECTION OF THE ENZYMATIC ACTIVITY OF BIOMARKERS | TETMEDICAL INC (US) | 2025-07-31 | — | — | US | claimed |
| CN-119985761-A | Method for quantitatively analyzing energy metabolites of glucose metabolism pathway in kidney tissue of mice based on LC-MS/MS detection method | 上海大学 | 2025-05-13 | — | — | CN | claimed |
| CN-119955767-A | In vitro reconstitution of the calvin cycle system | 中国科学院遗传与发育生物学研究所 | 2025-05-09 | — | — | CN | claimed |
| CN-119816897-A | Multiple study assessment | 普罗科技有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119291187-A | Biomarker combination and application thereof glioblastoma application in screening | 南方医科大学珠江医院 | 2025-01-10 | — | — | CN | claimed |
| US-12188008-B2 | Recombinant host cells and methods for the production of glyceric acid and downstream products | LYGOS, INC. (US) | 2025-01-07 | — | — | US | claimed |
| US-20240360434-A1 | METHOD FOR ISOLATING NUCLEIC ACIDS FROM A FORMALDEHYDE RELEASER STABILIZED SAMPLE | QIAGEN GMBH (DE) | 2024-10-31 | — | — | US | claimed |
| US-20060111848-A1 | Identification and use of cofactor independent phosphoglycerate mutase as a drug target for pathogenic organisms and treatment of the same | NEW ENGLAND BIOLABS, INC. (US) | 2006-05-25 | — | — | US | claimed |
| EP-1595957-A1 | Phosphoglycerate mutases and enzyme products | Eigenbrodt, Erich (DE) | 2005-11-16 | — | — | EP | claimed |
| WO-2005020886-A2 | IDENTIFICATION AND USE OF COFACTOR INDEPENDENT PHOSPHOGLYCERATE MUTASE AS A DRUG TARGET | NEW ENGLAND BIOLABS, INC. (US) | 2005-03-10 | — | — | WO | claimed |
| WO-2004081033-A2 | SYNTHESIS OF PROTEINS BY CELL-FREE PROTEIN EXPRESSION | NATIONAL INSTITUTES OF HEALTH (US) | 2004-09-23 | — | — | WO | claimed |
| US-6727076-B2 | UTILIZES A GEL FORMING MATRIX FOR THE RAPID SCREENING OF CLINICAL AND ENVIRONMENTAL CULTURES | BIOLOG, INC. | 2004-04-27 | — | — | US | claimed |
| WO-2003069344-A1 | ANTI-GLYCOLYTIC COMPOSITION | IC INNOVATIONS LTD (GB) | 2003-08-21 | — | — | WO | claimed |
| US-20030138868-A1 | Agents and method for diagnosing lyme disease and borreliosis vaccine | WITA GMBH (DE) | 2003-07-24 | — | — | US | claimed |
| US-6472201-B1 | GROWING AND TESTING MICROORGANISMS IN A MULTITEST FORMAT WHICH UTILIZES A GEL FORMING MATRIX FOR THE RAPID SCREENING OF CLINICAL AND ENVIRONMENTAL CULTURES | BIOLOG, INC. | 2002-10-29 | — | — | US | claimed |
| US-6017721-A | CONTACTING SERUM FROM A PATIENT WITH LIGANDS THAT BIND WARM AUTOANTIBODIES BUT DO NOT BIND ALLOANTIBODIES, SEPARATING NON-BOUND SERUM COMPONENTS FROM BOUND WARM AUTOANTIBODIES, USING WARM AUTOANTIBODY-DEPLETED SERUM IN ANTIGLOBIN TESTING | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-01-25 | — | — | US | claimed |
| US-5789186-A | ASSAYING PHOSPHOGLYCERIC ACID MUSTASE IN BLOOD | ORIENTAL YEAST CO., LTD. (JP) | 1998-08-04 | — | — | US | claimed |